Spatial Metabolomics of the Human Kidney using MALDI Trapped Ion Mobility Imaging Mass Spectrometry
- 15 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (19), 13084-13091
- https://doi.org/10.1021/acs.analchem.0c02051
Abstract
Low molecular weight metabolites are essential for defining the molecular phenotypes of cells. However, spatial metabolom-ics tools often lack the sensitivity, specify, and spatial resolution to provide comprehensive descriptions of these species in tissue. MALDI imaging mass spectrometry (IMS) of low molecular weight ions is particularly challenging as MALDI ma-trix clusters are often nominally isobaric with multiple metabolite ions, requiring high resolving power instrumentation or derivatization to circumvent this issue. An alternative to this is to perform ion mobility separation before ion detection, ena-bling the visualization of metabolites without the interference of matrix ions. Additional difficulties surrounding low weight metabolite visualization include high resolution imaging, while maintaining sufficient ion numbers for broad and representa-tive analysis of the tissue chemical complement. Here, we use MALDI timsTOF IMS to image low molecular weight me-tabolites at higher spatial resolution than most metabolite MALDI IMS experiments (20 µm) while maintaining broad cov-erage within the human kidney. We demonstrate that trapped ion mobility spectrometry (TIMS) can resolve matrix peaks from metabolite signal and separate both isobaric and isomeric metabolites with different distributions within the kidney. The added ion mobility data dimension dramatically increased the peak capacity for spatial metabolomics experiments. Through this improved sensitivity, we have found >40 low molecular weight metabolites in human kidney tissue such as arginic acid, acetylcarnitine, and choline that localize to the cortex, medulla, and renal pelvis, respectively. Future work will involve further exploring metabolomic profiles of human kidneys as a function of age, gender, and ethnicity.Other Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U54DK120058)
- National Institute of Allergy and Infectious Diseases (R01 AI138581)
- Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET?1828299)
- National Institute of General Medical Sciences (2P41GM103391)
This publication has 70 references indexed in Scilit:
- Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic ProfileScientific Reports, 2012
- Metabolomics in the study of kidney diseasesNature Reviews Nephrology, 2011
- Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass SpectrometryCancer Research, 2009
- Metabolomic profiling to develop blood biomarkers for Parkinson's diseaseBrain, 2008
- Metabolome analysis by capillary electrophoresis–mass spectrometryJournal of Chromatography A, 2007
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006
- Comparing and combining NMR spectroscopy and mass spectrometry in metabolomicsAnalytical and Bioanalytical Chemistry, 2006
- Capillary electrophoresis in metabolomicsTrAC Trends in Analytical Chemistry, 2006
- Metabolomic applications of electrochemistry/Mass spectrometryJournal of the American Society for Mass Spectrometry, 2004
- Quantitative Metabolome Analysis Using Capillary Electrophoresis Mass SpectrometryJournal of Proteome Research, 2003